UPDATE: 4/13/21 @ 10:30 A.M. (WLNS) FDA says pause of Johnson & Johnson COVID-19 vaccine to investigate clots to last ‘matter of days.’
<<<The Associated Press contributed to this report.
WASHINGTON (WLNS)– On Tuesday the FDA announced the agency was calling for a pause in the use of the Johnson & Johnson COVID-19 vaccine.
According to officials, as of yesterday, more than 6.8 million doses of the vaccine have been administered in the U.S. CDC & FDA are reviewing data involving 6 reported U.S. cases of a rare & severe type of blood clot in individuals after receiving the vaccine.
Right now, these adverse events appear to be extremely rare.
The CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential significance. The FDA will review that analysis as it also investigates these cases.
The FDA says they take vaccine side effects seriously, and will hold a news conference on YouTube at 10 A.M to provide more information.
#COVID19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following COVID-19 vaccination very seriously.— U.S. FDA (@US_FDA) April 13, 2021